CLINICAL_TRIALS
trial_result
· 2020-08-10
Clinical Trial Update: Enzastaurin in Combination of Capecitabine to Treat Breast Cancer [Phase 2]
Summary
Phase 2 trial of enzastaurin in combination with capecitabine for breast cancer was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-08-10